LDHA and non-small cell lung carcinoma: To further examine whether circRARS affected NSCLC proliferation by regulating LDHA activity, we treated NSCLC cells with GSK2837808A (LDHAi, 20 μM), an effective selective inhibitor of LDHA activity.